-
-
-
Human Resources
-
IND applications typically consist of three main sections.
Category:
Press Release
Release date:
2025-11-06
To achieve the above purpose, a complete IND application requires the submission of detailed documentation, which primarily includes:
1. Animal Pharmacology and Toxicology Studies
Purpose: Assess the drug's effects and potential toxicity in living organisms.
Content: This includes pharmacodynamics (how the drug works), pharmacokinetics (how the body processes the drug—absorption, distribution, metabolism, and excretion)—as well as toxicology studies (which help determine the safe dosage range and identify potential organ toxicity). This section forms the core of the safety evidence.
2. CMC (Chemistry, Manufacturing, and Controls)
Purpose: Ensure the consistent and reliable production of high-quality investigational drugs.
Content:
Chemical structure: Chemical characterization and structural confirmation of the drug.
Production process: How to manufacture and purify the drug.
Quality Control: Detailed quality standards and testing methods ensure that each batch of medication maintains consistent purity, potency, and composition.
Stability Data: Demonstrate that the drug remains stable throughout the planned study period.
3. Clinical Protocol and Investigator Information
Purpose: Demonstrate that the human trial design is both scientific and ethical.
Content:
Clinical protocol: Detailed description of the clinical trial's purpose, study design, inclusion/exclusion criteria, dosing regimen, dosage, and methods for assessing efficacy and safety.
Investigator's Brochure (IB): All known information about the drug is provided to clinical trial researchers to help them understand the medication and conduct the trials effectively.
Researcher qualifications: Verify that the principal clinical trial physician has the qualifications and experience necessary to conduct this study.
Ethics Committee Approval: The clinical trial protocol has been reviewed and approved by the Institutional Review Board or an independent Ethics Committee to safeguard the rights of participants.
Keywords:
Previous entry:
More information
Contact Us
You might also like to inquire
Changchun YunSci Biopharmaceutical Co. Ltd
Telephone：0431-80528606
Email：YCHT@yunsci.com
Website：www.yunsci.com
Address：No. 845 Shengde Avenue, Beihu Science and Technology Development Zone, Changchun City
Links:
Copyright: Changchun YunSci Biopharmaceutical Co. Ltd